[go: up one dir, main page]

SE9201331D0 - Protein l och hybridproteiner daerav - Google Patents

Protein l och hybridproteiner daerav

Info

Publication number
SE9201331D0
SE9201331D0 SE9201331A SE9201331A SE9201331D0 SE 9201331 D0 SE9201331 D0 SE 9201331D0 SE 9201331 A SE9201331 A SE 9201331A SE 9201331 A SE9201331 A SE 9201331A SE 9201331 D0 SE9201331 D0 SE 9201331D0
Authority
SE
Sweden
Prior art keywords
proteins
protein
sequences
relates
hybrid proteins
Prior art date
Application number
SE9201331A
Other languages
English (en)
Inventor
U Sjoebring
Original Assignee
Hightech Receptor C O Active
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hightech Receptor C O Active filed Critical Hightech Receptor C O Active
Priority to SE9201331A priority Critical patent/SE9201331D0/sv
Publication of SE9201331D0 publication Critical patent/SE9201331D0/sv
Priority to EP93912053A priority patent/EP0662086B1/en
Priority to DE69333042T priority patent/DE69333042T2/de
Priority to JP51918393A priority patent/JP3462209B2/ja
Priority to US08/325,278 priority patent/US6822075B2/en
Priority to PCT/SE1993/000375 priority patent/WO1993022342A1/en
Priority to US08/795,475 priority patent/US5965390A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9201331A 1992-04-28 1992-04-28 Protein l och hybridproteiner daerav SE9201331D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9201331A SE9201331D0 (sv) 1992-04-28 1992-04-28 Protein l och hybridproteiner daerav
EP93912053A EP0662086B1 (en) 1992-04-28 1993-04-28 Protein l and hybrid proteins thereof
DE69333042T DE69333042T2 (de) 1992-04-28 1993-04-28 Protein l und entsprechenden proteinhybriden
JP51918393A JP3462209B2 (ja) 1992-04-28 1993-04-28 プロテインｌおよびそのハイブリッドプロテイン類
US08/325,278 US6822075B2 (en) 1992-04-28 1993-04-28 Protein L and hybrid proteins thereof
PCT/SE1993/000375 WO1993022342A1 (en) 1992-04-28 1993-04-28 Protein l and hybrid proteins thereof
US08/795,475 US5965390A (en) 1992-04-28 1997-02-11 Protein L and hybrid proteins thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201331A SE9201331D0 (sv) 1992-04-28 1992-04-28 Protein l och hybridproteiner daerav

Publications (1)

Publication Number Publication Date
SE9201331D0 true SE9201331D0 (sv) 1992-04-28

Family

ID=20386082

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9201331A SE9201331D0 (sv) 1992-04-28 1992-04-28 Protein l och hybridproteiner daerav

Country Status (6)

Country Link
US (2) US6822075B2 (sv)
EP (1) EP0662086B1 (sv)
JP (1) JP3462209B2 (sv)
DE (1) DE69333042T2 (sv)
SE (1) SE9201331D0 (sv)
WO (1) WO1993022342A1 (sv)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
US7037680B2 (en) * 1993-09-21 2006-05-02 The United States Of America As Represented By The Secretary Of The Army Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
AUPM885194A0 (en) * 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
EP0935612A4 (en) 1996-03-26 2001-12-12 Amrad Operations Pty Ltd Precursors of catalytic antibodies
AUPO930697A0 (en) * 1997-09-19 1997-10-09 Walter And Eliza Hall Institute Of Medical Research, The Catalytic antibodies and a method of producing same
US20040154053A1 (en) * 1998-03-20 2004-08-05 Wyatt Paul Signal transduction protein involved in plant dehiscence
WO2000015803A1 (en) * 1998-09-14 2000-03-23 Affitech As Immunoglobulin binding protein
US7345217B2 (en) 1998-09-22 2008-03-18 Mendel Biotechnology, Inc. Polynucleotides and polypeptides in plants
US8124348B2 (en) 2000-08-23 2012-02-28 Jonathan Zmuda Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes
US7939715B2 (en) 2000-11-16 2011-05-10 Mendel Biotechnology, Inc. Plants with improved yield and stress tolerance
TWI317736B (en) * 2000-12-19 2009-12-01 Sembiosys Genetics Inc Methods for the production of redox proteins and heteromultimeric-protein-complexes, and related compositions related applications
US7098383B2 (en) * 2000-12-19 2006-08-29 Sembiosys Genetics Inc. Methods for the production of multimeric immunoglobulins, and related compositions
US20030167524A1 (en) * 2000-12-19 2003-09-04 Rooijen Gijs Van Methods for the production of multimeric protein complexes, and related compositions
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
US8426678B2 (en) 2002-09-18 2013-04-23 Mendel Biotechnology, Inc. Polynucleotides and polypeptides in plants
US7255867B2 (en) * 2002-11-15 2007-08-14 Id Biomedical Corporation Of Quebec Vaccine
WO2004076634A2 (en) * 2003-02-24 2004-09-10 Ira Sanders Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
JP2005112827A (ja) * 2003-10-10 2005-04-28 National Institute Of Advanced Industrial & Technology 抗体アフィニティ担体
WO2005113584A1 (en) * 2004-04-29 2005-12-01 Board Of Regents, University Of Texas System Methods and compositions comprising protein l immunoglobulin binding domains for cell-specific targeting
WO2006127682A2 (en) * 2005-05-20 2006-11-30 Smithkline Beecham Corporation Novel methods
US7741128B2 (en) * 2005-05-23 2010-06-22 University Of Hawaii Cooperative reporter systems, components, and methods for analyte detection
US10822396B2 (en) 2009-12-15 2020-11-03 MuHyeon CHOE Repeat-chain for the production of dimer, multimer, multimer complex and super-complex
PT2771364T (pt) 2011-10-27 2019-09-10 Genmab As Produção de proteínas heterodiméricas
KR101722054B1 (ko) * 2013-05-30 2017-03-31 최무현 반복사슬과 단량체의 복합체 간의 교차결속에 의해 형성된 초복합체 및 이의 용도
US9569513B1 (en) * 2013-09-10 2017-02-14 Amazon Technologies, Inc. Conditional master election in distributed databases
US10494414B2 (en) 2014-08-28 2019-12-03 Kaneka Corporation Immunoglobulin G-binding peptide
JP6369807B2 (ja) * 2014-10-21 2018-08-08 株式会社プロテイン・エクスプレス プロテインｌ変異体
CN107108700B (zh) 2014-12-17 2023-02-17 思拓凡生物工艺研发有限公司 修饰的κ轻链-结合多肽
WO2016121701A1 (ja) 2015-01-26 2016-08-04 株式会社カネカ 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス
JP6663360B2 (ja) 2015-01-26 2020-03-11 株式会社カネカ 変異型免疫グロブリンκ鎖可変領域結合性ペプチド
WO2017191747A1 (ja) * 2016-05-06 2017-11-09 株式会社カネカ κ鎖可変領域を含むタンパク質の製造方法
WO2017195638A1 (ja) 2016-05-09 2017-11-16 株式会社カネカ 抗体またはκ鎖可変領域含有抗体断片の精製方法
JP6983419B2 (ja) * 2017-02-08 2021-12-17 国立大学法人東京工業大学 抗原検出又は測定用キット
TWI874341B (zh) 2018-12-18 2025-03-01 美商健生生物科技公司 產生異二聚體抗體之方法
US11492667B2 (en) 2020-06-12 2022-11-08 New England Biolabs, Inc. Compositions and methods for detecting molecular targets on chromosomal DNA
WO2022216157A1 (en) * 2021-04-09 2022-10-13 Stichting Radboud Universiteit Off the shelf proximity biotinylation enzyme
GB202112386D0 (en) 2021-08-31 2021-10-13 Cytiva Bioprocess R & D Ab Modified kappa light chain-binding polypeptides
GB202203640D0 (en) 2022-03-16 2022-04-27 Cytiva Bioprocess R & D Ab Alkali-stabilized kappa light chain-binding separation matrix
AU2023288640A1 (en) 2022-06-22 2024-12-12 Cytiva Bioprocess R&D Ab Kappa light chain-binding convection matrix
JP2026503790A (ja) 2023-02-06 2026-01-29 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 溶出条件の最適化

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE459503B (sv) * 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
US5312901A (en) 1986-02-14 1994-05-17 Pharmacia Lkb Biotechnology Ab Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
SE459662B (sv) 1986-03-21 1989-07-24 Pharmacia Ab Hybrid-dna-molekyl som kodar foer ett protein med samma igg specificitet som protein g, plasmid innehaallande densamma samt foerfarande foer framstaellning av proteinet
US4876194A (en) * 1986-07-22 1989-10-24 Hightech Receptor Ab Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
JP2871709B2 (ja) * 1988-11-21 1999-03-17 住友製薬株式会社 免疫グロブリンｇ結合活性を有する新規な蛋白質プロテインｈ、該蛋白質をコードする遺伝子及び該蛋白質の製造法
SE466259B (sv) * 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
SE9002212D0 (sv) * 1990-06-21 1990-06-21 Hightech Receptor Ab Igg binding protein
US5736362A (en) * 1990-10-26 1998-04-07 The University Of Melbourne Ryegrass pollen allergen
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
DK0640135T3 (da) * 1992-05-07 2001-02-05 Affitech As Immunoglobulinbindende proteiner, der er afledt af protein L, og anvendelser af disse
US5977336A (en) * 1993-03-16 1999-11-02 St. Louis University High molecular weight surface proteins of non-typeable haemophilus
WO2000015803A1 (en) * 1998-09-14 2000-03-23 Affitech As Immunoglobulin binding protein
GB9929937D0 (en) * 1999-12-17 2000-02-09 Actinova Ltd Antigen delivery

Also Published As

Publication number Publication date
DE69333042T2 (de) 2004-05-06
US6822075B2 (en) 2004-11-23
EP0662086B1 (en) 2003-06-11
WO1993022342A1 (en) 1993-11-11
EP0662086A1 (en) 1995-07-12
JPH07506573A (ja) 1995-07-20
US5965390A (en) 1999-10-12
JP3462209B2 (ja) 2003-11-05
DE69333042D1 (de) 2003-07-17
US20030027283A1 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
SE9201331D0 (sv) Protein l och hybridproteiner daerav
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CA2290485A1 (en) Method for the production of non-immunogenic proteins
DE69429925D1 (de) METHODE ZUR BINDUNG VON MATERIAL AN DAS Beta-AMYLOID-PEPTID
ATE130765T1 (de) Gentechnologisch veränderte immunglobuline.
ATE353362T1 (de) Neuartige ctla4/cd28 liganden und deren anwendungen
DK19290D0 (da) Molekulaer samling af antistofgener, antistoffer fremstillet derved samt anvendelse deraf
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
DE69932813D1 (de) Nukleinsäurebindungsproteine
WO2003092630A3 (en) Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries
DE60025832D1 (de) Mehrere zytokin-antikörper komplexen
DK0851868T3 (da) Höjniveau-ekspression af proteiner
EP0332424A3 (en) Chimeric antibodies directed against human carcinoembryonic antigen
GB9307371D0 (en) Fusion proteins
WO1997008314A3 (en) Telomere repeat binding factor and diagnostic and therapeutic use thereof
DE59309458D1 (de) Synthetische Peptide, Antikörper dagegen und ihre Verwendung
DE69433690D1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
WO1998021333A3 (en) Nucleic acid encoding schwannomin-binding-proteins and products related thereto
DE69333382D1 (de) Hyaluronan rezeptor (rezeptor durch hyaluronan verurzachte bewelichkeit) und hyaluronan bindende peptide
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
EP1576157A4 (en) FLUORESCENCE PROTEINS FROM COPEPODA SPECIES AND METHOD FOR USE THEREOF
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
NZ500151A (en) A general method for attaching DNA molecule comprising non-antibody target molecule (eg. CTLA-4 or L-selectin), antigen or epitope sequence, and optionally a polypeptide sequence
DE69632457D1 (de) Neue menschliche proteine, die cyclin abhängigen kinasen ähneln, sowie methoden zu deren verwendung